The Biospecimen Management Consortium is an industry-led consortium with the shared objective of driving sample excellence in clinical research. The BMC is currently accepting sponsor and clinical research site member organizations that are committed to challenging the status quo. The BMC openly welcomes novel ideas and suggested areas of improvement within the scope of biospecimen lifecycle management.
For more information, visit www.biospecimen-consortium.org
Company Details
- Employees
- 4
- Founded
- -
- Address
- The Critical Challenges That Working With Biospecimens Can Introduce.
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Biospecimen Management Consortium (Bmc) Questions
Biospecimen Management Consortium (Bmc)'s website is http://www.biospecimen-consortium.org
Biospecimen Management Consortium (Bmc)'s LinkedIn profile is https://www.linkedin.com/company/biospecimen-consortium
Biospecimen Management Consortium (Bmc) has
4 employees.
View email and phone details for 4
employees at Biospecimen Management Consortium (Bmc).
Biospecimen Management Consortium (Bmc)'s industry is
Biotechnology Research
Biospecimen Management Consortium (Bmc)'s top competitors are
Arcus Biosciences,
Beam Therapeutics,
Biospecimen Industry Collaboration,
Halda Therapeutics,
Astellas Pharma,
Tonix Pharmaceuticals,
Biontech Se,
Clearpath Clinical Research,
Labconnect,
Slope.
Biospecimen Management Consortium (Bmc)'s categories are Biotechnology Research
Biospecimen Management Consortium (Bmc)'s founding year is 2024
